Addus HomeCare Corporation Stock

Equities

ADUS

US0067391062

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
114.8 USD +2.76% Intraday chart for Addus HomeCare Corporation +2.87% +23.65%
Sales 2024 * 1.14B Sales 2025 * 1.2B Capitalization 1.86B
Net income 2024 * 73M Net income 2025 * 82M EV / Sales 2024 * 1.62 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.54 x
P/E ratio 2024 *
25.8 x
P/E ratio 2025 *
22.9 x
Employees 20,453
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.94%
More Fundamentals * Assessed data
Dynamic Chart
Stephens Adjusts Addus HomeCare Price Target to $128 From $120, Maintains Overweight Rating MT
RBC Raises Price Target on Addus HomeCare to $129 From $102, Keeps Outperform Rating Amid 'Solid' Q1 Results MT
RBC Raises Price Target on Addus HomeCare to $129 From $102, Keeps Outperform Rating MT
Hcs-Girling Holdco, Llc announced a definitive agreement to acquire New York operations of Addus HomeCare Corporation for $23 million. CI
Transcript : Addus HomeCare Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM
BofA Securities Adjusts Addus HomeCare Price Target to $118 From $115, Maintains Buy Rating MT
Transcript : Addus HomeCare Corporation, Q1 2024 Earnings Call, May 07, 2024
Addus HomeCare Q1 Adjusted Earnings, Revenue Advance MT
Addus HomeCare Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (ADUS) ADDUS HOMECARE CORPORATION Reports Q1 Revenue $280.7M, vs. Street Est of $280.4M MT
Earnings Flash (ADUS) ADDUS HOMECARE CORPORATION Posts Q1 EPS $1.21, vs. Street Est of $1.09 MT
Addus HomeCare 'Disappointed' with Compensation Requirement in Medicaid Final Rule; Shares Tumble Pre-Bell MT
Barclays Downgrades Addus HomeCare to Underweight From Equalweight, Cuts Price Target to $83 From $88 MT
Barclays Initiates Addus HomeCare With Equalweight Rating, Price Target is $88 MT
Addus Homecare Insider Sold Shares Worth $413,763, According to a Recent SEC Filing MT
More news
1 day+2.76%
1 week+2.87%
1 month+19.41%
3 months+24.41%
6 months+31.66%
Current year+23.65%
More quotes
1 week
110.02
Extreme 110.015
115.10
1 month
96.39
Extreme 96.39
115.10
Current year
85.94
Extreme 85.94
115.10
1 year
78.35
Extreme 78.35
115.10
3 years
68.57
Extreme 68.57
115.10
5 years
43.13
Extreme 43.125
129.01
10 years
15.33
Extreme 15.33
129.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 10-09-30
Director of Finance/CFO 51 16-05-09
President 61 17-01-15
Members of the board TitleAgeSince
Chief Executive Officer 68 10-09-30
Director/Board Member 68 14-02-28
Director/Board Member 59 06-07-26
More insiders
Date Price Change Volume
24-05-31 114.8 +2.76% 144,559
24-05-30 111.7 +0.71% 66,731
24-05-29 110.9 -0.78% 58,127
24-05-28 111.8 +0.18% 89,941
24-05-24 111.6 +2.36% 63,377

Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT

More quotes
Addus HomeCare Corporation is engaged in providing home care services. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
114.8 USD
Average target price
117 USD
Spread / Average Target
+1.91%
Consensus